AKHIR BULAN
By : KUNTO AJI
CMaj7 Dm7 CMaj7 Dm7
selalu seperti ini berjalan
CMaj7 Dm7 CMaj7 Dm7
derita paska senang-senang
Am D7 Am
aku dan keinginanku
F Fm
di atas kebutuhan
CMaj7 Dm7 CMaj7 Dm7
munkin kerasnya kehidupanmu
CMaj7 Dm7 CMaj7 Dm7
kerasnya arus pergaulan
Am D7 Am
aku dan keinginanku
F Fm
di atas kebutuhan
CMaj7
hidup di akhir bulan
Fm A#7 CMaj7
dengan teman mie instan
Fm A#7 CMaj7
hidup di akhir bulan
FM A#7 CMaj7 Fm A#7
aku harus bertahan
Am D7 Am
aku dan keinginanku
A#7
di atas kebutuhan
Int : CMaj7 F#m6 Fm6 4x
CMaj7
hidup di akhir bulan
Fm A#7 CMaj7
dengan teman mie instan
Fm A#7 CMaj7
hidup di akhir bulan
FM A#7 CMaj7 Fm A#7
aku harus bertahan
CMaj7 Fm A#7 CMaj7
(hidupku hanya rotasi) takkan berkesudahan
Fm A#7 CMaj7
(pasang surut terus berganti) dalam lingkaran setan
Fm A#7 CMaj7 Fm A#7 CMaj7
(hidupku hanya rotasi, aku harus merubah diri)
Am D7 Am
aku dan keinginanku
D7 Am
dan jiwa mudaku
A#7
di atas kebutuhan
It's the Catch-22 of clinical trials: to protect pregnant women and children from the risks of untested drugs....we don't test drugs adequately for them. In the last few decades , we've been more concerned about the harms of research than of inadequately tested treatments for everyone, in fact. But for "vulnerable populations," like pregnant women and children, the default was to exclude them. And just in case any women might be, or might become, pregnant, it was often easier just to exclude us all from trials. It got so bad, that by the late 1990s, the FDA realized regulations and more for pregnant women - and women generally - had to change. The NIH (National Institutes of Health) took action too. And so few drugs had enough safety and efficacy information for children that, even in official circles, children were being called "therapeutic orphans." Action began on that, too. There is still a long way to go. But this month there was a sign that ...
Comments
Post a Comment